Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis

Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

John W. Eikelboom, Jack Hirsh, Jeffrey I. Weitz et al. · Circulation · 2002 · 1.1K citations · Full text

Medicine, Cardiology, Pharmacology +15

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

Martine Gilard, Jean‐Christophe Cornily, Grégoire Le Gal et al. · Journal of the American College of Cardiology · 2008 · 1K citations

Medicine, Pharmacology, Pharmacotherapy +13

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.

S.M. de Morais, G. Wilkinson, Joyce Blaisdell et al. · Journal of Biological Chemistry · 1994 · 952 citations · Full text

Medicine, Genetics, Pharmacology +17

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

Jean‐Sébastien Hulot · Blood · 2006 · 929 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Variability in platelet responsiveness to clopidogrel among 544 individuals

Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger et al. · Journal of the American College of Cardiology · 2005 · 778 citations

Medicine, Clinical Pharmacokinetics, Hematology +12